CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Andras Bilkei-Gorzo - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andras Bilkei-Gorzo

ORCID: 0000-0002-6805-0472↗

Public evidence

7 connected articles

Bidirectional Effect of Long-Term Δ<sup>9</sup>-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome.2024 · Europe PMC Chronic low-dose Δ<sup>9</sup>-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice.2023 · Europe PMC Regulation of adult neurogenesis by the endocannabinoid-producing enzyme diacylglycerol lipase alpha (DAGLa).2022 · Europe PMC Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis.2022 · Europe PMC Efficacy of Δ<sup>9</sup> -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice.2021 · Europe PMC Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain.2018 · Europe PMC Cannabinoid 1 Receptor Signaling on Hippocampal GABAergic Neurons Influences Microglial Activity.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.